{
  "title": "Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv",
  "url": "https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1",
  "summary": [
    {
      "type": "bullet",
      "text": "**KEY FINDING**: 67% of GI cancer patients completed assessments, lowering early discontinuation risk by ~30%, with consistent results across prognostic groups."
    },
    {
      "type": "bullet",
      "text": "**TACTICAL WIN [SHIP NOW]**: Automate day-3 reminders to improve symptom assessment completion rates among patients."
    },
    {
      "type": "bullet",
      "text": "**MARKET SIGNAL [ðŸ”´ URGENT]**: FDA now mandates PRO data in trials within 12 months, emphasizing clinical validity of patient-reported outcomes."
    },
    {
      "type": "bullet",
      "text": "**CONCERN**: Study limited by self-selection bias; healthier patients may complete assessments more frequently."
    }
  ],
  "model": "granite4:tiny-h"
}